Home
Conditions
Pharyngeal Diseases

Clinical trial condition

Pharyngeal Diseases

Explore clinical trials studying Pharyngeal Diseases. Study availability and eligibility vary by location and protocol.

1,560 public trials 361 recruiting studies

Refine in advanced search Browse all conditions

Pharyngeal Diseases trial results

Active, Not Recruiting

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT04533750

Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, +34 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

View all 27 locations

View Trial Details

Active, Not Recruiting

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

NCT04708470

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +49 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

NCT04667585

Conditions: Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, +7 more
Locations: Duke University Medical Center Durham, North Carolina, United States

Duke Raleigh Hospital Raleigh, North Carolina, United States

View Trial Details

Active, Not Recruiting

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

NCT03224000

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

NCT05784012

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations: Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain

Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain

Hospital Clinic de Barcelona Barcelona, Catalonia, Spain

Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain

View Trial Details

Active, Not Recruiting

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

NCT04825990

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Asst Degli Spedali Civili Di Brescia Brescia, Italy

View Trial Details

Active, Not Recruiting

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

NCT05211232

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: The Affiliated Hospital of Guangdong Medical College Zhanjiang, Guangdong, China

Wuzhou Red Cross Hospital Wuzhou, Guangxi, China

Guizhou Cancer Hospital Guiyang, Guizhou, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Active, Not Recruiting

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

NCT05145660

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, China

View Trial Details

Active, Not Recruiting

Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients

NCT02253238

Conditions: Dehydration, Head and Neck Cancer, Head and Neck Neoplasms, +20 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

NCT04432597

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Pharyngeal Diseases

Pharyngeal Diseases trial results

Related conditions